Catalyst Wire Dossier Catalyst Wire Dossier

Haplo-Cord HSCT

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Haplo-Cord HSCT, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia [NA]

See pricing